Breaking News

ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies

Aims to provide improved product tracking, scheduling and live monitoring of the manufacturing status across the entire CGT supply chain from vein to vein.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ATMPS Ltd, a provider of blockchain-based “vein to vein” cell orchestration platforms for advanced therapies, and Ori Biotech, an innovator in cell and gene therapy (CGT) manufacturing platforms, entered a global collaboration integrate their respective data platforms to support the development of advanced therapies.   The non-exclusive partnership will result in the integration of Ori’s CGT manufacturing platform’s data architecture with ATMPS’ Hataali, a secure data sharing platform, special...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters